Supernus Pharmaceuticals (SUPN)
(Delayed Data from NSDQ)
$29.74 USD
+0.34 (1.14%)
Updated Apr 22, 2024 11:55 AM ET
After-Market: $29.69 -0.05 (-0.15%) 7:58 PM ET
5-Strong Sell of 5 5
D Value D Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $0.39 | 0.00% |
Earnings Summary
For their last quarter, Supernus Pharmaceuticals (SUPN) reported earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.41 per share. This reflects a negative earnings surprise of 95.12%. Look out for SUPN's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of $0.39 per share, reflecting a year-over-year increase of 34.48%.
Earnings History
Price & Consensus
Zacks News for SUPN
Supernus Pharmaceuticals (SUPN) Lags Q4 Earnings Estimates
SUPN: What are Zacks experts saying now?
Zacks Private Portfolio Services